By |

Profile

Galapagos is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Contact Information

Website: www.glpg.com
Email: ir@glpg.com
Main Phone: +32 15342900
Address: Generaal De Wittelaan L11 A3
Address 2: Suite 4000
State: AB
City / Town: Mechelen
Country: BEL
Postal Code: 2800

Issuer Information

Exchange: NGS
CEO: Onno van de Stolpe
Employees: 712
NAICS: Pipeline Transportation of Crude Oil(486110)


Gathering Data... Please wait

Profile

Galapagos is a clinical-stage biotechnology company, involved in the discovery and development of small-molecule medicines. The company's product candidate portfolio includes Filgotinib, a JAK1 inhibitor to treat rheumatoid arthritis, Crohn's disease, and ulcerative colitis; novel therapies in cystic fibrosis (a chronic disease that affects the lungs and digestive system); GLPG1690, a selective autotaxin inhibitor with potential application in idiopathic pulmonary disease; GLPG1972 to treat osteoarthritis; and MOR106 to treat atopic dermatitis.

Contact Information

Website: www.glpg.com
Email: ir@glpg.com
Main Phone: +32 15342900
Address: Generaal De Wittelaan L11 A3
Address 2: Suite 4000
State: AB
City / Town: Mechelen
Country: BEL
Postal Code: 2800

Issuer Information

Exchange: NGS
CEO: Onno van de Stolpe
Employees: 712
NAICS: Pipeline Transportation of Crude Oil(486110)
$ 106.26 $ 1.91 (1.83%)
Last Price 106.26 Change $ 1.91 Change % 1.83 Tick N/A
Bid 104.88 Bid Size 1,000.00 Ask 105.09 Ask Size 800.00
Open 104.83 High 106.26 Low 104.83 Prev Close 104.35
Last Trade Volume 59,453 52 Wk Hi 122.28 52 Wk Low 85.00
Market Cap 5.8 bi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 54,465,421.00 EPS (TTM) -1.82 PE Ratio N/A Exchange NGS
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 139 139 139 139
Low Target Price Estimate 98 98 98 98
Mean Target Price Estimate 118 118 118 118
Standard Deviation 15.4 15.4 15.4 15.4
Date of Most Recent Estimate 05/01/18 05/01/18 05/01/18 05/01/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 5 5 5
Moderate Buy 1 1 1 1
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1.36 1.36 1.36 1.36